Cargando…

Integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial

INTRODUCTION: Integrated care is effective in reducing all-cause mortality in patients with atrial fibrillation (AF) in primary care, though time and resource intensive. The aim of the current study was to assess whether integrated care should be directed at all AF patients equally. METHODS: The ALL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trinks-Roerdink, Emmy M., Geersing, Geert-Jan, van den Dries, Carline J., Hemels, Martin E. W., Rienstra, Michiel, van Gelder, Isabelle C., van Smeden, Maarten, van Klaveren, David, Kent, David M., Rutten, Frans H., van Doorn, Sander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586661/ https://www.ncbi.nlm.nih.gov/pubmed/37856486 http://dx.doi.org/10.1371/journal.pone.0292586

Ejemplares similares

Benefit of integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial
por: Trinks-Roerdink, E M, et al.
Publicado: (2023)

External validation and updating of prediction models of bleeding risk in patients with cancer receiving anticoagulants
por: Trinks-Roerdink, EM, et al.
Publicado: (2023)

Anticoagulants in frail elderly patients with atrial fibrillation: a delicate balance
por: Trinks-Roerdink, Emmy M., et al.
Publicado: (2023)

Clinical consequences of off-label reduced dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis
por: Joosten, Linda P T, et al.
Publicado: (2023)

COVID-19-isolatiespreekuren tijdens de ‘eerste golf’: Een beschrijving van de patiënten
por: van Royen, Florien, et al.
Publicado: (2021)

Cardiovascular vulnerability predicts hospitalisation in primary care clinically suspected and confirmed COVID-19 patients: A model development and validation study
por: van Royen, Florien S., et al.
Publicado: (2022)

Incidence and individual risk prediction of post-COVID-19 cardiovascular disease in the general population: a multivariable prediction model development and validation study
por: la Roi-Teeuw, Hannah M, et al.
Publicado: (2023)

The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation
por: van den Dries, Carline J., et al.
Publicado: (2020)

Integrated management of atrial fibrillation in primary care: results of the ALL-IN cluster randomized trial
por: van den Dries, Carline J, et al.
Publicado: (2020)

Safety of off‐label dose reduction of non‐vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
por: van den Dries, Carline J., et al.
Publicado: (2022)

A systematic review and meta-analysis of diagnostic delay in pulmonary embolism
por: van Maanen, R., et al.
Publicado: (2022)

Antithrombotic management of patients with atrial fibrillation—Dutch anticoagulant initiatives anno 2020
por: Chu, G., et al.
Publicado: (2020)

Risk of cardiac and non-cardiac adverse events in community-dwelling older patients with atrial fibrillation: a prospective cohort study in the Netherlands
por: van Doorn, Sander, et al.
Publicado: (2018)

Incidence and outcome of atrial fibrillation: diversity throughout Europe
por: Rienstra, Michiel, et al.
Publicado: (2021)

Integrated management of atrial fibrillation including tailoring of anticoagulation in primary care: study design of the ALL-IN cluster randomised trial
por: van den Dries, Carline J, et al.
Publicado: (2017)

B-PO05-137 ARRHYTHMIC BURDEN AND THEIR PROGNOSTIC EFFECT ON MORTALITY IN HOSPITALIZED COVID-19 PATIENTS
por: Offerhaus, Joost, et al.
Publicado: (2021)

Managing the Increasing Burden of Atrial Fibrillation through Integrated Care in Primary Care: A Cost-Effectiveness Analysis
por: van den Dries, Carline J., et al.
Publicado: (2023)

Atrial fibrillation and heart failure temporality: does it matter?
por: Van Deutekom, Colinda, et al.
Publicado: (2022)

Sex- and age specific association of new-onset atrial fibrillation with in-hospital mortality in hospitalised COVID-19 patients
por: Offerhaus, Joost A., et al.
Publicado: (2022)

Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation
por: Chu, Gordon, et al.
Publicado: (2020)

Optimising telephone triage of patients calling for acute shortness of breath during out-of-hours primary care: protocol of a multiple methods study (Opticall)
por: Spek, Michelle, et al.
Publicado: (2022)

Estimated causal effects of common respiratory infections on cardiovascular risk: a meta-analysis
por: la Roi-Teeuw, Hannah M, et al.
Publicado: (2023)

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial
por: Joosten, Linda P T, et al.
Publicado: (2019)

Update on management of atrial fibrillation in heart failure: a focus on ablation
por: Mulder, Bart A, et al.
Publicado: (2022)

Telomere length and incident atrial fibrillation – data of the PREVEND cohort
por: Siland, Joylene E., et al.
Publicado: (2017)

Time of onset of atrial fibrillation and atrial fibrillation progression data from the RACE V study
por: van de Lande, Martijn E, et al.
Publicado: (2023)

Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort
por: Van Deutekom, Colinda, et al.
Publicado: (2023)

Management of superficial venous thrombosis based on individual risk profiles: protocol for the development and validation of three prognostic prediction models in large primary care cohorts
por: van Royen, F. S., et al.
Publicado: (2021)

Atrial fibrillation: trends in prevalence and antithrombotic prescriptions in the community
por: Joosten, L. P. T., et al.
Publicado: (2022)

Young-onset atrial fibrillation: Sex differences in clinical profile, progression rate and cardiovascular outcome()
por: Marcos, Ernaldo G., et al.
Publicado: (2019)

Lifestyle components: Self-reported physical activity, nutritional status, sleep quality and incident atrial fibrillation
por: Siland, Joylene E., et al.
Publicado: (2020)

Relation of overweight and symptomatic atrial fibrillation: A case report
por: de Maat, Gijs E., et al.
Publicado: (2015)

European Primary Care Cardiovascular Society (EPCCS) consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care
por: Hobbs, FD Richard, et al.
Publicado: (2015)

The effects of misclassification in routine healthcare databases on the accuracy of prognostic prediction models: a case study of the CHA2DS2-VASc score in atrial fibrillation
por: van Doorn, S., et al.
Publicado: (2017)

Hybrid atrial fibrillation ablation in patients with persistent atrial fibrillation or failed catheter ablation
por: Al-Jazairi, M. I. H., et al.
Publicado: (2019)

Complex clinical scenarios with the use of direct oral anticoagulants in patients with atrial fibrillation: a multidisciplinary expert advisory board
por: Mulder, B. A., et al.
Publicado: (2020)

Sex-related differences in risk factors, outcome, and quality of life in patients with permanent atrial fibrillation: results from the RACE II study
por: Kloosterman, Mariëlle, et al.
Publicado: (2019)

Real-life impact of clinical prediction rules for venous thromboembolism in primary care: a cross-sectional cohort study
por: van Maanen, Rosanne, et al.
Publicado: (2020)

Clustering of cardiovascular and renal comorbidities and risk of incident atrial fibrillation in the community-based PREVEND cohort
por: Van Deutekom, C, et al.
Publicado: (2023)

Brady- and tachyarrhythmias detected by continuous rhythm monitoring in paroxysmal atrial fibrillation
por: Frausing, Maria Hee Jung Park, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j8o4qt2u0kask47ij2kvrkk15i